Profound Medical ( ($TSE:PRN) ) has provided an announcement. Profound Medical Corp. has closed a private placement of 921,428 common shares to ...
TORONTO, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”) is pleased to announce that it has completed its previously announced private ...
An update from Profound Medical ( ($TSE:PRN) ) is now available. Profound Medical Corp. has upsized its previously announced private placement to ...
Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”) is pleased to announce that it has increased the size of its private placement previously announced on December 19, 2025 ...
Profound Medical Celebrates The Hong Center’s 200th Independent TULSA Procedure for Prostate Disease
Renowned urologist Dr. Mark Hong sets new global benchmark for urologist-led, MRI-guided prostate treatment, leading a growing movement toward incision-free prostate therapy TORONTO, Nov. 18, 2025 ...
Profound Medical Celebrates The Hong Center's 200Th Independent TULSA Procedure For Prostate Disease
(MENAFN- GlobeNewsWire - Nasdaq) Renowned urologist Dr. Mark Hong sets new global benchmark for urologist-led, MRI-guided prostate treatment, leading a growing movement toward incision-free prostate ...
Profound Medical Celebrates The Hong Center's 200th Independent TULSA Procedure for Prostate Disease
TORONTO, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) ("Profound" or the "Company"), a commercial-stage medical device company that develops and markets AI-powered, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results